These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11100907)

  • 1. Absorption and disposition including enterohepatic circulation of (14C) roquinimex after oral administration to healthy volunteers.
    Strandgården K; Höglund P; Grönquist L; Svensson L; Gunnarsson PO
    Biopharm Drug Dispos; 2000 Mar; 21(2):53-67. PubMed ID: 11100907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution rate-limited absorption and complete bioavailability of roquinimex in man.
    Strandgârden K; Höglund P; Nordle O; Polacek J; Wännman H; Gunnarsson PO
    Biopharm Drug Dispos; 1999 Oct; 20(7):347-54. PubMed ID: 10760843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of roquinimex in mouse and rat: an in vitro/in vivo comparison.
    Tuvesson H; Strandgården K; Nordle O; Gunnarsson PO; Seidegård J; Persson R
    Xenobiotica; 2000 Apr; 30(4):371-80. PubMed ID: 10821166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first clinical pilot study of roquinimex (Linomide) in cancer patients with special focus on immunological effects.
    Bergh JC; Tötterman TH; Termander BC; Strandgarden KA; Gunnarsson PO; Nilsson BI
    Cancer Invest; 1997; 15(3):204-11. PubMed ID: 9171853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose.
    Waldmeier F; Kaiser G; Ackermann R; Faigle JW; Wagner J; Barner A; Lasseter KC
    Xenobiotica; 1991 Feb; 21(2):251-61. PubMed ID: 2058180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).
    Seaber E; On N; Dixon RM; Gibbens M; Leavens WJ; Liptrot J; Chittick G; Posner J; Rolan PE; Pack RW
    Br J Clin Pharmacol; 1997 Jun; 43(6):579-87. PubMed ID: 9205817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J; Chen X; Zhong D
    Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Mice: Potential Enterohepatic Circulation and Target-Mediated Disposition.
    Guan X; Morris ME
    Pharm Res; 2019 Dec; 37(1):5. PubMed ID: 31823112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of 14C-radioactivity after oral intake of a single dose of 14C-labeled fampridine (4-aminopyridine) in healthy volunteers.
    Blight AR; Henney HR
    Clin Ther; 2009 Feb; 31(2):328-35. PubMed ID: 19302905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of methyldopa in man.
    Kwan KC; Foltz EL; Breault GO; Baer JE; Totaro JA
    J Pharmacol Exp Ther; 1976 Aug; 198(2):264-77. PubMed ID: 781212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterohepatic circulation of clioquinol in the rat.
    Kotaki H; Yamamura Y; Tanimura Y; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1984 Jun; 7(6):420-5. PubMed ID: 6237189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil.
    Muirhead GJ; Rance DJ; Walker DK; Wastall P
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):13S-20S. PubMed ID: 11879255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption, metabolism and excretion after oral administration of a new Ca antagonist, 14C-benidipine hydrochloride to man.
    Kobayashi H; Kobayashi S; Dalrymple PD; Wood SG; Chasseaud LF
    Xenobiotica; 1997 Jun; 27(6):597-608. PubMed ID: 9211659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disposition of feprazone and its hydroxylated metabolite in human volunteers.
    Berry D; Parke DV
    Xenobiotica; 1988 Jul; 18(7):857-68. PubMed ID: 3176523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects.
    Patrick JE; Kosoglou T; Stauber KL; Alton KB; Maxwell SE; Zhu Y; Statkevich P; Iannucci R; Chowdhury S; Affrime M; Cayen MN
    Drug Metab Dispos; 2002 Apr; 30(4):430-7. PubMed ID: 11901097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zero-order absorption and linear disposition of oral colchicine in healthy volunteers.
    Thomas G; Girre C; Scherrmann JM; Francheteau P; Steimer JL
    Eur J Clin Pharmacol; 1989; 37(1):79-84. PubMed ID: 2591469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.